An intriguing connection has emerged between BlackRock and the XRPL, raising questions about potential institutional involvement in a blockchain project called DNA Protocol. Market commentator Pumpius suggests that BlackRock’s iShares Genomics and Healthcare ETF may be linked to this decentralized initiative through a shared ticker symbol (XDNA). [citation needed] Pumpius draws parallels between the asset manager’s established presence and the discreet online presence of the DNA Protocol, raising suspicions about an indirect connection. [citation needed] The XRP Ledger, known for its low transaction fees, rapid settlement speeds, and strong banking ties, has attracted attention from institutions seeking to tokenize high-value data. Pumpius highlights this as a key factor in the potential success of DNA Protocol. [citation needed] However, Pumpius’ claims remain unverified, and neither BlackRock nor Ripple have commented on these allegations. Despite the lack of confirmation, the topic has sparked discussions about the role of institutional involvement in blockchain projects. [citation needed] Further investigation is warranted to clarify this potential connection.